Another study demonstrated that CRC patients with BRAF or KRAS mutated tumors were more likely to have an elevated serum level of carbohydrate antigen (CA19-9) and carcinoma embryonic antigen (CEA) [61]. Here, BRAF is linked to colorectal carcinoma.